Medical device site joint infection

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
4 Unique IMPs
1 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 1
J Anti-infectives (ATC J) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Supportive / diluent 1 substance
Phase II/III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II/III

1 trial
  • Centre Hospitalier Universitaire De Nantes Academic
    RIFAMPICIN
    2022-502974-18-00 1 country 2023 n=235
    Recruiting

Phase II

1 trial
  • Phagenix Commercial
    PP1493; PP1815; SODIUM CHLORIDE
    2024-516555-40-00 3 countries n=51
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Phagenix Commercial 1 Phase II 0
Centre Hospitalier Universitaire De Nantes Academic 1 Phase II/III 1
New trials by year
2023
1
← All indication landscapes